352 related articles for article (PubMed ID: 17503533)
1. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
Yoon JJ; Chung HJ; Park TG
J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
[TBL] [Abstract][Full Text] [Related]
2. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
Yoon JJ; Chung HJ; Lee HJ; Park TG
J Biomed Mater Res A; 2006 Dec; 79(4):934-42. PubMed ID: 16941589
[TBL] [Abstract][Full Text] [Related]
3. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
4. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
5. Photo-cross-linkable and thermo-responsive hydrogels containing chitosan and Pluronic for sustained release of human growth hormone (hGH).
Yoo HS
J Biomater Sci Polym Ed; 2007; 18(11):1429-41. PubMed ID: 17961325
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels.
Chun KW; Lee JB; Kim SH; Park TG
Biomaterials; 2005 Jun; 26(16):3319-26. PubMed ID: 15603827
[TBL] [Abstract][Full Text] [Related]
8. Chitosan/pluronic hydrogel containing bFGF/heparin for encapsulation of human dermal fibroblasts.
Choi JS; Yoo HS
J Biomater Sci Polym Ed; 2013; 24(2):210-23. PubMed ID: 23565598
[TBL] [Abstract][Full Text] [Related]
9. Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis.
Kim MS; Bhang SH; Yang HS; Rim NG; Jun I; Kim SI; Kim BS; Shin H
Tissue Eng Part A; 2010 Oct; 16(10):2999-3010. PubMed ID: 20486788
[TBL] [Abstract][Full Text] [Related]
10. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
Matsui M; Tabata Y
Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
[TBL] [Abstract][Full Text] [Related]
11. Pluronic/chitosan hydrogels containing epidermal growth factor with wound-adhesive and photo-crosslinkable properties.
Choi JS; Yoo HS
J Biomed Mater Res A; 2010 Nov; 95(2):564-73. PubMed ID: 20725966
[TBL] [Abstract][Full Text] [Related]
12. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
[TBL] [Abstract][Full Text] [Related]
13. Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery.
Chung HJ; Lee Y; Park TG
J Control Release; 2008 Apr; 127(1):22-30. PubMed ID: 18234389
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
[TBL] [Abstract][Full Text] [Related]
15. DNA nanogels composed of chitosan and Pluronic with thermo-sensitive and photo-crosslinking properties.
Lee JI; Kim HS; Yoo HS
Int J Pharm; 2009 May; 373(1-2):93-9. PubMed ID: 19429293
[TBL] [Abstract][Full Text] [Related]
16. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.
Zieris A; Prokoph S; Levental KR; Welzel PB; Grimmer M; Freudenberg U; Werner C
Biomaterials; 2010 Nov; 31(31):7985-94. PubMed ID: 20674970
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
[TBL] [Abstract][Full Text] [Related]
18. Preparation of TGF-β1-conjugated biodegradable pluronic F127 hydrogel and its application with adipose-derived stem cells.
Jung HH; Park K; Han DK
J Control Release; 2010 Oct; 147(1):84-91. PubMed ID: 20599451
[TBL] [Abstract][Full Text] [Related]
19. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan.
Lee KW; Yoon JJ; Lee JH; Kim SY; Jung HJ; Kim SJ; Joh JW; Lee HH; Lee DS; Lee SK
Transplant Proc; 2004 Oct; 36(8):2464-5. PubMed ID: 15561282
[TBL] [Abstract][Full Text] [Related]
20. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration.
Hosseinkhani H; Hosseinkhani M; Khademhosseini A; Kobayashi H; Tabata Y
Biomaterials; 2006 Dec; 27(34):5836-44. PubMed ID: 16930687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
